IA
TRIB

IFP Advisors’s Trinity Biotech TRIB Stock Holding History

IFP Advisors’s Portfolio TRIB Stock Details TRIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-48
Closed -$1K – 3857
2018
Q3 		$1K Hold
48
– – ﹤0.01% 3726
2018
Q2 		$1K Sell
48
-54
-53% -$1.3K ﹤0.01% 3777
2018
Q1 		$3K Hold
102
– – ﹤0.01% 3413
2017
Q4 		$3K Buy
102
+48
+89% +$1.24K ﹤0.01% 3463
2017
Q3 		$2K Hold
54
– – ﹤0.01% 3798
2017
Q2 		$2K Hold
54
– – ﹤0.01% 3773
2017
Q1 		$2K Hold
54
– – ﹤0.01% 3696
2016
Q4 		$2K Hold
54
– – ﹤0.01% 3680
2016
Q3 		$4K Hold
54
– – ﹤0.01% 3362
2016
Q2 		$3K Buy
+54
New +$3.04K ﹤0.01% 3376
2016
Q1 		– Sell
-54
Closed -$3K – 3372
2015
Q4 		$3K Buy
+54
New +$3.19K ﹤0.01% 3222

Other funds holding TRIB

SCM
Stonehill Capital Management New York $197M AUM 96.45% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
FWSM
First Wilshire Securities Management Pasadena, California $444M AUM 42.88% 1-Year Est. Return
HAIM
Hunter Associates Investment Management Pittsburgh, Pennsylvania $756M AUM 19.99% 1-Year Est. Return
2L
22NW LP Seattle, Washington $146M AUM 29.83% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
LAM
Lapides Asset Management Greenwich, Connecticut $153M AUM 9.03% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

IFP Advisors's TRIB Position: Q4 2018 in Review

IFP Advisors sold out of Trinity Biotech (TRIB) in Q4 2018, closing a stake of 48 shares — an estimated $1K sold.

IFP Advisors first reported a position in TRIB in Q4 2015 and held it in 11 quarters. The position peaked at $4K in Q3 2016. 41 funds tracked by Wall St. Rank hold TRIB as of Q4 2018.

  • IFP Advisors reported no remaining Trinity Biotech position as of Q4 2018 after selling out during the quarter.
  • IFP Advisors sold 48 Trinity Biotech shares in Q4 2018, an estimated $1K.
  • IFP Advisors first reported a position in Trinity Biotech in Q4 2015 and held it in 11 quarters.
  • IFP Advisors's Trinity Biotech position peaked at $4K in Q3 2016.
  • 41 funds tracked by Wall St. Rank held Trinity Biotech as of Q4 2018.

Based on IFP Advisors's 13F filing for Q4 2018, filed 23 Jan 2019.